A detailed history of Omers Administration Corp transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Omers Administration Corp holds 351,600 shares of GOSS stock, worth $443,016. This represents 0.0% of its overall portfolio holdings.

Number of Shares
351,600
Holding current value
$443,016
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$0.85 - $1.53 $298,860 - $537,948
351,600 New
351,600 $386,000
Q1 2024

May 14, 2024

BUY
$0.8 - $1.51 $51,680 - $97,546
64,600 New
64,600 $76,000

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $118M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Omers Administration Corp Portfolio

Follow Omers Administration Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.